Can BPAF, a newer BPA substitute, increase breast cancer risk?

What's actually in it

BPAF (bisphenol AF) is one of several chemicals used to replace BPA in plastics and resins. It shows up in electronic components, specialty plastics, food packaging, and coatings. Compared to BPA, BPAF has extra fluorine atoms that make it more stable and harder for the body to break down.

The progesterone receptor is a key switch in breast tissue. It controls cell growth during the menstrual cycle and pregnancy. When the wrong chemicals flip this switch, breast cells can grow out of control.

What the research says

A 2026 structural analysis study in Environ Sci Technol compared how BPA and BPAF interact with the progesterone receptor. Using molecular modeling and binding simulations, the researchers found that BPAF binds to the progesterone receptor more tightly than BPA.

That tighter binding means BPAF is more effective at activating the receptor. Once activated, it triggered gene expression patterns associated with breast cancer development and growth. The study showed that BPAF turned on cell proliferation genes and turned down tumor suppressor genes.

The irony is clear: a chemical chosen as a safer BPA replacement may actually be worse at this specific cancer pathway. Structural substitution doesn't mean safety substitution.

Consumers can't tell from a label whether a product contains BPAF. The safest route is to minimize contact with all bisphenol-containing materials by choosing glass, stainless steel, and ceramic for food and drinks.